Katwijk Chemie Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM VALPROATE POWDER, with a corresponding US DMF Number 18007.
Remarkably, this DMF maintains an Active status since its submission on January 12, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 12, 2015, and payment made on September 25, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II